WallStSmart

Coherent Inc (COHR)vsItron Inc (ITRI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coherent Inc generates 181% more annual revenue ($6.60B vs $2.35B). ITRI leads profitability with a 12.3% profit margin vs 7.1%. ITRI appears more attractively valued with a PEG of 0.72. ITRI earns a higher WallStSmart Score of 57/100 (C).

COHR

Buy

56

out of 100

Grade: C

Growth: 7.3Profit: 5.0Value: 5.0Quality: 7.5
Piotroski: 5/9Altman Z: 1.53

ITRI

Buy

57

out of 100

Grade: C

Growth: 3.3Profit: 6.5Value: 6.0Quality: 7.5
Piotroski: 4/9Altman Z: 1.79
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for COHR.

ITRISignificantly Overvalued (-22.8%)

Margin of Safety

-22.8%

Fair Value

$81.31

Current Price

$80.07

$1.24 premium

UndervaluedFair: $81.31Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COHR4 strengths · Avg: 8.8/10
EPS GrowthGrowth
73.0%10/10

Earnings expanding 73.0% YoY

Market CapQuality
$83.52B9/10

Large-cap with strong market position

PEG RatioValuation
0.928/10

Growing faster than its price suggests

Revenue GrowthGrowth
20.5%8/10

Revenue surging 20.5% year-over-year

ITRI4 strengths · Avg: 8.5/10
Debt/EquityHealth
0.0810/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.728/10

Growing faster than its price suggests

P/E RatioValuation
12.9x8/10

Attractively priced relative to earnings

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

Areas to Watch

COHR4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.534/10

Distress zone — elevated risk

Return on EquityProfitability
4.4%3/10

ROE of 4.4% — below average capital efficiency

Profit MarginProfitability
7.1%3/10

7.1% margin — thin

P/E RatioValuation
204.3x2/10

Premium valuation, high expectations priced in

ITRI3 concerns · Avg: 2.7/10
Altman Z-ScoreHealth
1.794/10

Distress zone — elevated risk

Revenue GrowthGrowth
-3.3%2/10

Revenue declined 3.3%

EPS GrowthGrowth
-16.9%2/10

Earnings declined 16.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : COHR

The strongest argument for COHR centers on EPS Growth, Market Cap, PEG Ratio. Revenue growth of 20.5% demonstrates continued momentum. PEG of 0.92 suggests the stock is reasonably priced for its growth.

Bull Case : ITRI

The strongest argument for ITRI centers on Debt/Equity, PEG Ratio, P/E Ratio. PEG of 0.72 suggests the stock is reasonably priced for its growth.

Bear Case : COHR

The primary concerns for COHR are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 204.3x leaves little room for execution misses.

Bear Case : ITRI

The primary concerns for ITRI are Altman Z-Score, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

COHR profiles as a growth stock while ITRI is a declining play — different risk/reward profiles.

COHR carries more volatility with a beta of 2.05 — expect wider price swings.

COHR is growing revenue faster at 20.5% — sustainability is the question.

ITRI generates stronger free cash flow (79M), providing more financial flexibility.

Bottom Line

ITRI scores higher overall (57/100 vs 56/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coherent Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a variety of scientific, commercial, and industrial research applications. The company is headquartered in Santa Clara, California.

Itron Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Itron, Inc., a technology and services company, offers end-to-end solutions that help manage energy, water, and smart city operations globally. The company is headquartered in Liberty Lake, Washington.

Want to dig deeper into these stocks?